Deutsche Bank Downgrades Ligand Pharma (LGND) to Sell; Stock Ahead of Itself

November 20, 2017 6:48 AM EST Send to a Friend
Deutsche Bank downgraded Ligand Pharma (NASDAQ: LGND) from Hold to Sell with a price target of $105.00 (from $104.00).Analyst Esther ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login